Close

Ratings by Cantor Fitzgerald (Louise Chen)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/1/2024 Novo Nordisk NVO Maintain Overweight
(N/A)
 
 
  Details
12/14/2023 Pfizer PFE Maintain Overweight
(N/A)
 
 
  Details
12/1/2023 Novo Nordisk NVO New Coverage Overweight
(N/A)
101.84
(123.45)
21.22% Details
11/14/2023 Aclaris Therapeutis ACRS Downgrade Neutral
(Overweight)
4.76
(1.19)
-75% Details
10/24/2023 Adlai Nortye Ltd. ANL New Coverage Overweight
(N/A)
9.08
(7.15)
-21.26% Details
10/16/2023 Immunovant IMVT Maintain Overweight
(N/A)
 
 
  Details
9/12/2023 Lyra Therapeutics LYRA Maintain Overweight
(N/A)
 
 
  Details
9/8/2023 Atossa Genetics ATOS New Coverage Overweight
(N/A)
0.74
(0.98)
32.43% Details
8/22/2023 Aravive Inc. ARAV Downgrade Neutral
(Buy)
0.22
(0.04)
-81.82% Details
8/10/2023 Zai Lab ZLAB New Coverage Overweight
(N/A)
26.38
(19.94)
-24.41% Details
6/27/2023 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
5/19/2023 Ambrx Biopharma AMAM New Coverage Overweight
(N/A)
13.77
(27.94)
102.9% Details
5/12/2023 VYNE Therapeutics VYNE Maintain Overweight
(N/A)
 
 
  Details
5/10/2023 Cutera CUTR Maintain Neutral
(N/A)
 
 
  Details
4/5/2023 Johnson & Johnson JNJ Maintain Overweight
(N/A)
 
 
  Details
2/15/2023 Immunovant IMVT New Coverage Overweight
(N/A)
18.59
(37.00)
99.03% Details
1/11/2023 Humanigen HGEN New Coverage Neutral
(N/A)
0.16
(0.04)
-75% Details
1/10/2023 TherapeuticsMD TXMD New Coverage Neutral
(N/A)
5.33
(2.25)
-57.79% Details
1/10/2023 Cutera CUTR Downgrade Neutral
(Overweight)
31.04
(2.40)
-92.27% Details
12/19/2022 Merck MRK Maintain Overweight
(N/A)
 
 
  Details
11/9/2022 SCYNEXIS SCYX Maintain Overweight
(N/A)
 
 
  Details
11/7/2022 Avalo Therapeutics Inc. AVTX Maintain Overweight
(N/A)
 
 
  Details
11/3/2022 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
10/27/2022 Merck MRK Maintain Overweight
(N/A)
 
 
  Details
10/11/2022 SCYNEXIS SCYX Maintain Overweight
(Overweight)
 
 
  Details
9/26/2022 Roivant Sciences ROIV Maintain Overweight
(N/A)
 
 
  Details
8/30/2022 I-Mab IMAB Maintain Overweight
(N/A)
 
 
  Details
7/20/2022 Johnson & Johnson JNJ Maintain Overweight
(Overweight)
 
 
  Details
7/13/2022 ContraFect Corp. CFRX Downgrade Neutral
(Overweight)
2.79
(0.23)
-91.76% Details
7/13/2022 TherapeuticsMD TXMD Maintain Neutral
(Neutral)
 
 
  Details
7/13/2022 Hutchison China MediTech Ltd. HCM Maintain Overweight
(Overweight)
 
 
  Details
7/13/2022 Humanigen HGEN Downgrade Neutral
(Overweight)
3.02
(0.16)
-94.7% Details
7/7/2022 Arcutis Biotherapeutics Inc. ARQT Maintain Overweight
(Overweight)
 
 
  Details
6/22/2022 Amarin Corporation AMRN Maintain Overweight
(Overweight)
 
 
  Details
6/7/2022 Eli Lilly LLY Maintain Overweight
(Overweight)
 
 
  Details
6/6/2022 Arcutis Biotherapeutics Inc. ARQT Maintain Overweight
(Overweight)
 
 
  Details
6/6/2022 eFFECTOR Therapeutics, Inc. EFTR Maintain Overweight
(Overweight)
 
 
  Details
6/2/2022 Connect Biopharma Holdings Ltd CNTB New Coverage Overweight
(N/A)
0.75
(1.24)
65.33% Details
6/1/2022 Gracell Biotechnologies Inc GRCL New Coverage Overweight
(N/A)
3.29
(10.25)
211.55% Details
5/24/2022 Roivant Sciences ROIV Maintain Overweight
(Overweight)
 
 
  Details
5/24/2022 Lyra Therapeutics LYRA New Coverage Overweight
(N/A)
6.07
(5.30)
-12.69% Details
5/17/2022 TherapeuticsMD TXMD Maintain Neutral
(Neutral)
 
 
  Details
5/17/2022 Spero Therapeutics SPRO Maintain Overweight
(Overweight)
 
 
  Details
5/16/2022 ContraFect Corp. CFRX Maintain Overweight
(Overweight)
 
 
  Details
5/13/2022 VYNE Therapeutics VYNE Maintain Overweight
(Overweight)
 
 
  Details
5/12/2022 Aravive Inc. ARAV Maintain Overweight
(Overweight)
 
 
  Details
5/12/2022 Cidara Therapeutics CDTX Maintain Overweight
(Overweight)
 
 
  Details
5/6/2022 TherapeuticsMD TXMD Downgrade Neutral
(Overweight)
0.18
(2.25)
1150% Details
5/6/2022 Entasis Therapeutics ETTX Downgrade Neutral
(Overweight)
1.91
(2.19)
14.66% Details
5/3/2022 Cutera CUTR Maintain Overweight
(Overweight)
 
 
  Details
4/29/2022 Roivant Sciences ROIV New Coverage Overweight
(N/A)
3.86
(11.60)
200.52% Details
4/12/2022 I-Mab IMAB Maintain Overweight
(Overweight)
 
 
  Details
4/11/2022 Pfizer PFE Maintain Overweight
(Overweight)
 
 
  Details
4/8/2022 Eli Lilly LLY Maintain Overweight
(Overweight)
 
 
  Details
4/7/2022 VYNE Therapeutics VYNE Maintain Overweight
(Overweight)
 
 
  Details
4/7/2022 Pfizer PFE Maintain Overweight
(Overweight)
 
 
  Details
4/5/2022 Merck MRK Maintain Overweight
(Overweight)
 
 
  Details
4/1/2022 Johnson & Johnson JNJ Maintain Overweight
(N/A)
 
 
  Details
3/31/2022 Cutera CUTR Maintain Overweight
(N/A)
 
 
  Details
3/31/2022 Clarus CRXT Maintain Overweight
(N/A)
 
 
  Details
3/29/2022 Arcutis Biotherapeutics Inc. ARQT Maintain Overweight
(Overweight)
 
 
  Details
3/24/2022 ContraFect Corp. CFRX Maintain Overweight
(Overweight)
 
 
  Details
3/23/2022 Pfizer PFE Maintain Overweight
(Overweight)
 
 
  Details
3/17/2022 VYNE Therapeutics VYNE Maintain Overweight
(Overweight)
 
 
  Details
3/16/2022 eFFECTOR Therapeutics, Inc. EFTR Maintain Overweight
(Overweight)
 
 
  Details
3/10/2022 TherapeuticsMD TXMD Maintain Overweight
(Overweight)
 
 
  Details
3/8/2022 Cidara Therapeutics CDTX Maintain Overweight
(Overweight)
 
 
  Details
3/7/2022 TherapeuticsMD TXMD Maintain Overweight
(Overweight)
 
 
  Details
3/7/2022 VYNE Therapeutics VYNE Maintain Overweight
(Overweight)
 
 
  Details
3/4/2022 Evolus EOLS Maintain Overweight
(Overweight)
 
 
  Details
3/3/2022 Hutchison China MediTech Ltd. HCM Upgrade Overweight
(Overweight)
26.19
(15.72)
-39.98% Details
3/3/2022 Entasis Therapeutics ETTX Maintain Overweight
(Overweight)
 
 
  Details
3/2/2022 Avalo Therapeutics Inc. AVTX Maintain Overweight
(Overweight)
 
 
  Details
3/1/2022 Amarin Corporation AMRN Maintain Overweight
(Overweight)
 
 
  Details
3/1/2022 Johnson & Johnson JNJ Maintain Overweight
(Overweight)
 
 
  Details
3/1/2022 Humanigen HGEN Maintain Overweight
(Overweight)
 
 
  Details
2/24/2022 Aclaris Therapeutis ACRS Maintain Overweight
(Overweight)
 
 
  Details
2/23/2022 Arcutis Biotherapeutics Inc. ARQT Maintain Overweight
(Overweight)
 
 
  Details
2/23/2022 Cutera CUTR Maintain Overweight
(Overweight)
 
 
  Details
2/16/2022 Spero Therapeutics SPRO Maintain Overweight
(Overweight)
 
 
  Details
2/15/2022 Zoetis Inc. ZTS Maintain Overweight
(Overweight)
 
 
  Details
2/10/2022 SCYNEXIS SCYX Maintain Overweight
(Overweight)
 
 
  Details
2/8/2022 Pfizer PFE Maintain Overweight
(Overweight)
 
 
  Details
2/3/2022 Merck MRK Maintain Overweight
(Overweight)
 
 
  Details
2/3/2022 Eli Lilly LLY Maintain Overweight
(Overweight)
 
 
  Details
1/27/2022 Eli Lilly LLY Maintain Overweight
(Overweight)
 
 
  Details
1/26/2022 Evolus EOLS Maintain Overweight
(Overweight)
 
 
  Details
1/25/2022 Eli Lilly LLY Maintain Overweight
(Overweight)
 
 
  Details
1/24/2022 I-Mab IMAB Maintain Overweight
(Overweight)
 
 
  Details
1/24/2022 Johnson & Johnson JNJ Maintain Overweight
(Overweight)
 
 
  Details
1/13/2022 VYNE Therapeutics VYNE Maintain Overweight
(Overweight)
 
 
  Details
12/16/2021 Pfizer PFE Maintain Overweight
(N/A)
 
 
  Details
11/19/2021 Johnson & Johnson JNJ Maintain Overweight
(N/A)
 
 
  Details
11/10/2021 VYNE Therapeutics VYNE Maintain Overweight
(N/A)
 
 
  Details
11/4/2021 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
9/24/2021 Osmotica OSMT New Coverage Overweight
(N/A)
2.93
(1.11)
-62.12% Details
9/20/2021 Jaguar Animal Health JAGX Maintain Overweight
(N/A)
 
 
  Details
9/20/2021 Clarus CRXT New Coverage Overweight
(N/A)
8.81
(0.10)
-98.86% Details
9/13/2021 eFFECTOR Therapeutics, Inc. EFTR New Coverage Overweight
(N/A)
26.59
(11.12)
-58.18% Details
7/28/2021 Hutchison China MediTech Ltd. HCM Maintain Overweight
(N/A)
 
 
  Details
7/27/2021 Merck MRK Maintain Overweight
(N/A)
 
 
  Details
7/13/2021 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
7/13/2021 I-Mab IMAB Maintain Overweight
(N/A)
 
 
  Details
7/13/2021 Hutchison China MediTech Ltd. HCM Maintain Overweight
(N/A)
 
 
  Details
7/13/2021 Cutera CUTR Maintain Overweight
(N/A)
 
 
  Details
7/7/2021 Jaguar Animal Health JAGX New Coverage Overweight
(N/A)
1.49
(0.06)
-95.97% Details
6/28/2021 PDS Biotechnology Corp PDSB New Coverage Overweight
(N/A)
11.00
(5.42)
-50.73% Details
6/24/2021 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
6/11/2021 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
6/9/2021 I-Mab IMAB Maintain Overweight
(N/A)
 
 
  Details
6/4/2021 Cerecor CERC New Coverage Overweight
(N/A)
2.73
(2.93)
7.33% Details
6/2/2021 Cutera CUTR New Coverage Overweight
(N/A)
40.86
(2.40)
-94.13% Details
5/13/2021 Soliton SOLY Downgrade Neutral
(Overweight)
22.39
(22.58)
0.85% Details
4/16/2021 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
4/6/2021 Aclaris Therapeutis ACRS Maintain Overweight
(N/A)
 
 
  Details
4/6/2021 Soliton SOLY Maintain Overweight
(N/A)
 
 
  Details
3/10/2021 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
3/5/2021 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
2/22/2021 Evolus EOLS Maintain Overweight
(N/A)
 
 
  Details
2/22/2021 Humanigen HGEN Maintain Overweight
(N/A)
 
 
  Details
2/4/2021 I-Mab IMAB Maintain Overweight
(N/A)
 
 
  Details
2/2/2021 Soliton SOLY Maintain Overweight
(N/A)
 
 
  Details
2/2/2021 Aclaris Therapeutis ACRS Maintain Overweight
(N/A)
 
 
  Details
1/29/2021 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
1/26/2021 Johnson & Johnson JNJ Maintain Overweight
(N/A)
 
 
  Details
1/19/2021 Aclaris Therapeutis ACRS Maintain Overweight
(N/A)
 
 
  Details
1/6/2021 SCYNEXIS SCYX New Coverage Overweight
(N/A)
7.17
(1.68)
-76.57% Details
1/5/2021 Ardelyx, Inc ARDX New Coverage Overweight
(N/A)
6.47
(6.47)
0% Details
1/5/2021 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
12/28/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
11/5/2020 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
10/26/2020 Eli Lilly LLY Maintain Overweight
(Overweight)
 
 
  Details
10/21/2020 Humanigen HGEN New Coverage Overweight
(N/A)
13.44
(0.04)
-99.7% Details
9/9/2020 Entasis Therapeutics ETTX New Coverage Overweight
(N/A)
2.76
(2.19)
-20.65% Details
9/8/2020 I-Mab IMAB Maintain Overweight
(N/A)
 
 
  Details
9/8/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
8/6/2020 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
8/4/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
8/3/2020 Johnson & Johnson JNJ Maintain Overweight
(N/A)
 
 
  Details
7/27/2020 I-Mab IMAB New Coverage Overweight
(N/A)
29.93
(1.64)
-94.52% Details
7/23/2020 Pfizer PFE Maintain Overweight
(Overweight)
 
 
  Details
7/15/2020 Soliton SOLY New Coverage Overweight
(N/A)
7.34
(22.58)
207.63% Details
7/9/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
6/15/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
6/9/2020 ContraFect Corp. CFRX New Coverage Overweight
(N/A)
5.04
(2.79)
-44.64% Details
6/1/2020 Pfizer PFE Maintain Overweight
(N/A)
 
 
  Details
5/22/2020 Evolus EOLS Maintain Overweight
(N/A)
 
 
  Details
4/28/2020 Johnson & Johnson JNJ Maintain Overweight
(Overweight)
 
 
  Details
4/24/2020 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
4/14/2020 Amarin Corporation AMRN Maintain Overweight
(Overweight)
 
 
  Details
4/3/2020 Johnson & Johnson JNJ Maintain Overweight
(Overweight)
 
 
  Details
3/19/2020 Pfizer PFE Maintain Overweight
(Overweight)
 
 
  Details
2/25/2020 Arcutis Biotherapeutics Inc. ARQT New Coverage Overweight
(N/A)
27.05
(9.68)
-64.21% Details
2/24/2020 Aravive Inc. ARAV Maintain Overweight
(Overweight)
 
 
  Details
2/18/2020 Eli Lilly LLY Maintain Overweight
(Overweight)
 
 
  Details
2/12/2020 Teva Pharma TEVA Maintain Neutral
(N/A)
 
 
  Details
1/29/2020 Pfizer PFE Maintain Overweight
(Overweight)
 
 
  Details
1/27/2020 Aridis Pharmaceuticals ARDS Maintain Overweight
(N/A)
 
 
  Details
1/27/2020 Cidara Therapeutics CDTX Maintain Overweight
(N/A)
 
 
  Details
1/23/2020 Johnson & Johnson JNJ Maintain Overweight
(Overweight)
 
 
  Details
1/21/2020 Perrigo Co. PRGO Maintain Overweight
(N/A)
 
 
  Details
1/13/2020 Perrigo Co. PRGO Maintain Overweight
(N/A)
 
 
  Details
1/13/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 Amneal Pharmaceuticals AMRX Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 Horizon Therapeutics HZNP Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 Bausch Health Companies BHC Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 Merck MRK Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 Johnson & Johnson JNJ Maintain Overweight
(N/A)
 
 
  Details
1/8/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
1/8/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
1/7/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
1/2/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
12/20/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
12/10/2019 Aravive Inc. ARAV New Coverage Overweight
(N/A)
10.73
(0.04)
-99.63% Details
12/2/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
12/2/2019 Eli Lilly LLY Maintain Overweight
(Overweight)
 
 
  Details
11/20/2019 Johnson & Johnson JNJ New Coverage Overweight
(N/A)
134.83
(161.84)
20.03% Details
11/14/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
11/8/2019 Horizon Pharma HZNP Maintain Overweight
(N/A)
 
 
  Details
11/6/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
10/29/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
10/17/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
9/25/2019 TherapeuticsMD TXMD Maintain Overweight
(N/A)
 
 
  Details
9/20/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
9/16/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
9/11/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
9/9/2019 Eli Lilly LLY Maintain Overweight
(Overweight)
 
 
  Details
9/3/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
8/15/2019 Mallinckrodt plc MNK Maintain Overweight
(N/A)
 
 
  Details
8/15/2019 TherapeuticsMD TXMD Maintain Overweight
(N/A)
 
 
  Details
8/15/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
8/9/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
8/9/2019 Aclaris Therapeutis ACRS Maintain Overweight
(N/A)
 
 
  Details
8/7/2019 Allergen AGN Maintain Neutral
(N/A)
 
 
  Details
8/6/2019 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
7/31/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
7/29/2019 Mylan MYL Maintain Overweight
(N/A)
 
 
  Details
7/24/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
7/24/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
7/16/2019 Spero Therapeutics SPRO Maintain Overweight
(N/A)
 
 
  Details
7/12/2019 Mallinckrodt plc MNK Maintain Overweight
(N/A)
 
 
  Details
7/12/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
7/11/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
7/2/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
6/14/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 TherapeuticsMD TXMD Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 Teva Pharma TEVA Maintain Neutral
(N/A)
 
 
  Details
6/12/2019 Perrigo Co. PRGO Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 Neos Therapeutics NEOS Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 Mylan MYL Maintain Neutral
(N/A)
 
 
  Details
6/12/2019 Mallinckrodt plc MNK Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 Endo International plc ENDP Maintain Neutral
(N/A)
 
 
  Details
6/12/2019 Cidara Therapeutics CDTX Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 Amneal Pharmaceuticals AMRX Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 Allergen AGN Maintain Neutral
(N/A)
 
 
  Details
6/12/2019 Aclaris Therapeutis ACRS Maintain Overweight
(N/A)
 
 
  Details
5/31/2019 Bausch Health Companies BHC Maintain Overweight
(N/A)
 
 
  Details
5/31/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
5/29/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
5/2/2019 Teva Pharma TEVA Maintain Neutral
(N/A)
 
 
  Details
4/8/2019 Theravance Biopharma TBPH Maintain Overweight
(N/A)
 
 
  Details
4/3/2019 Horizon Pharma HZNP Maintain Overweight
(N/A)
 
 
  Details
4/2/2019 Foamix Pharmaceuticals FOMX Maintain Overweight
(N/A)
 
 
  Details
4/2/2019 Mylan MYL Maintain Neutral
(N/A)
 
 
  Details
4/1/2019 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
4/1/2019 Merck MRK Maintain Overweight
(N/A)
 
 
  Details
3/28/2019 Theravance Biopharma TBPH Maintain Overweight
(N/A)
 
 
  Details
3/28/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
3/25/2019 Dermira DERM Maintain Overweight
(N/A)
 
 
  Details
3/18/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
3/12/2019 Theravance Biopharma TBPH Maintain Overweight
(N/A)
 
 
  Details
2/27/2019 Horizon Pharma HZNP Maintain Overweight
(N/A)
 
 
  Details
2/22/2019 Merck MRK New Coverage Overweight
(N/A)
79.43
(129.45)
62.97% Details
2/12/2019 Dermira DERM Maintain Overweight
(N/A)
 
 
  Details
2/6/2019 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
1/25/2019 Foamix Pharmaceuticals FOMX Maintain Overweight
(N/A)
 
 
  Details
1/11/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
12/27/2018 Aridis Pharmaceuticals ARDS Maintain Overweight
(N/A)
 
 
  Details
11/30/2018 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
11/13/2018 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
10/19/2018 Endo International plc ENDP Maintain Neutral
(Neutral)
 
 
  Details
10/17/2018 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
10/17/2018 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
10/17/2018 Pfizer PFE Maintain Overweight
(Overweight)
 
 
  Details
10/12/2018 Foamix Pharmaceuticals FOMX New Coverage Overweight
(N/A)
5.00
(2.99)
-40.2% Details
10/4/2018 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
9/27/2018 Heron Therapeutics HRTX Maintain Overweight
(N/A)
 
 
  Details
9/27/2018 Teva Pharma TEVA Maintain Neutral
(N/A)
 
 
  Details
9/26/2018 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
9/24/2018 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
9/10/2018 Aridis Pharmaceuticals ARDS New Coverage Overweight
(N/A)
13.30
(0.31)
-97.67% Details
9/7/2018 Menlo Therapeutics MNLO New Coverage Overweight
(N/A)
7.60
(1.35)
-82.24% Details
9/5/2018 Dermira DERM Maintain Overweight
(N/A)
 
 
  Details